Compass Therapeutics (CMPX) Treasury Shares (2023 - 2025)
Historic Treasury Shares for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to $1.3 million.
- Compass Therapeutics' Treasury Shares fell 6513.91% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 6513.91%. This contributed to the annual value of $3.8 million for FY2024, which is 15106.67% up from last year.
- Per Compass Therapeutics' latest filing, its Treasury Shares stood at $1.3 million for Q3 2025, which was down 6513.91% from $2.9 million recorded in Q2 2025.
- Over the past 5 years, Compass Therapeutics' Treasury Shares peaked at $3.8 million during Q4 2024, and registered a low of $1.3 million during Q3 2025.
- Over the past 3 years, Compass Therapeutics' median Treasury Shares value was $2.9 million (recorded in 2025), while the average stood at $2.6 million.
- In the last 5 years, Compass Therapeutics' Treasury Shares surged by 15106.67% in 2024 and then crashed by 6513.91% in 2025.
- Quarter analysis of 3 years shows Compass Therapeutics' Treasury Shares stood at $1.5 million in 2023, then soared by 151.07% to $3.8 million in 2024, then crashed by 66.06% to $1.3 million in 2025.
- Its Treasury Shares stands at $1.3 million for Q3 2025, versus $2.9 million for Q2 2025 and $2.9 million for Q1 2025.